1300 361 795
Health Care Practitioner
Grow
NSW
Genea - World Leading Fertility
Health Care Practitioner
Grow
NSW
  • About Genea
    • Ethical Governance
    • Our Businesses
    • Our Vision and Values
  • Careers at Genea
  • Partnerships
  • Media and News
  • Our policy on sharing patient stories
Map Marker
NSW
- Is this your current location?
Yes / No
Question Mark
What is your current location?
ACT
NSW
VIC
WA
Other
Question Mark
Genea Group About Genea Ethical Governance Board of Directors

Genea Board of Directors

The Genea Board comprises a group of very experienced business professionals and doctors with extensive backgrounds in a range of financial and healthcare fields.

The Board is accountable to the Company’s shareholders for its performance.

Dr Robert Woolcott

Co-Chairman, Genea Board

Robert joined the Genea Board as a Non-Executive Director of Genea Limited in January 2011. He was elected joint Chairman of the Board in September 2019.

He is Chairman of the Medical Practice Committee, a member of the Audit Committee, the Risk and Compliance Committee and the Remuneration and Nominations Committee. He is Medical and Management Director of Genea Newcastle and Chief Medical Officer of Genea Biomedx.

Robert graduated as a Bachelor of Medicine/Bachelor of Surgery with honours in 1981 and has 33 years of experience in IVF and reproductive microsurgery. He undertook the Advanced Management Program at Harvard Business School in 2007.

He is a former member of the RANZCOG Reproductive Endocrinology and Infertility subspecialist sub-committee, the Hunter Post Graduate Medical Institute Board and the Mayne Health Medical Advisory Board.

Ka King (Eric) Cheng

Co-Chairman, Genea Board

Aldworth Equity Management Limited Founding Partner

Eric joined the Genea Board as an Executive Director in December 2018. He was elected joint Chairman of the Board in September 2019.

Eric is the Founding Partner of Aldworth Equity Management Limited and has over 28 years of experience in the banking industry with geographic coverage over China, Hong Kong, Macau and SE Asia. He has worked in various senior postings for BNP Paribas, Credit Suisse, UBS, Standard Chartered Bank and HSBC.

Eric graduated in 1990 with a Bachelor of Business Studies and obtained a Master of Finance from City University of Hong Kong.

Hoi Kwong (Eddie) Hon

Aldworth Equity Management Limited Partner and Chief Operating Officer

Eddie joined the Genea Board as an Executive Director in January 2019.

Eddie is the Partner and COO of Aldworth Equity Management Limited. He has over 20 years of experience in finance, banking, operations and business development. He has also previously held various senior positions in listed and multinational companies.

Eddie graduated with a Bachelor of Economics from the University of Hong Kong in 1996 achieved an MBA from the University of South Australia in 2014.

Zhang Xiaochun

WeDoctor Co-founder and CSO

Mr Zhang Xiaochun co-founded WeDoctor with Liao Jieyuan in 2010 and now serves as its CSO. He has a master's degree from Dongbei University of Finance and Economics and has worked in the Internet industry since 2000. He was the former CEO of Galaxy Internet Television was also the general manager of CNR New Media, a subsidiary of CNR (China National Radio) Media Group.

Ni Zhijing (Kevin)

WeDoctor Finance Vice President

Mr Ni Zhijing (Kevin) is the Finance Vice President of WeDoctor. Graduated from Shanghai University of Finance and Economics, he joined Price Waterhouse Coopers in 2007. Kevin has extensive practical experience in audit and assurance service to private, MNC and state-owned entities in China. He has been involved in a variety of onshore and offshore IPOs, debt restructurings, and mergers & acquisitions projects. Kevin is a member of the Chinese Institute of Certified Public Accountants (“CICPA”).

Dr Tomas Stojanov

Genea Chief Executive Officer

Tomas was appointed Genea Chief Executive Officer in January 2011 and joined the Genea Board as an Executive Director at the same time. 
With more than 26 years of experience in the health, biotechnology and agriculture sectors in a range of capacities, Tomas has conducted scientific research and has worked in operational management and commercialisation roles. Immediately prior to his appointment as CEO of Genea, Tomas was Director of Research and General Manager of Stem Cells and Research.

More information

Corporate and ethical governance
Diversity at Genea
Risk Management
Whistle blower policy

Your enquiry

Genea Fertility has legal obligations to protect your personal information and to provide you with details about how we deal with this information. Please read our Privacy Policy and Collection Statement.


Contact Us
Our response to Novel Coronavirus (COVID-19)
For all enquiries, call:
1300 361 795
Email us
Quicklinks
Genea Fertility
Genea Consult
Genea Biomedx
 
Resources
News
Life at Genea

Genea Citrix
Genea O365
Stay Connected

Subscribe to receive information and notice of events relating to fertility. Privacy Policy and Collection Statement

SUBSCRIBE
LinkedIn Instagram Twitter FaceBook
Genea shares patient stories to help people experiencing infertility to understand that they are not alone. Hearing about other people experiencing the same challenges is a powerful way to break the isolation and stigma that often surrounds infertility. We share these stories with the intent to inform, educate and comfort and have no intention to create unreasonable expectations of beneficial treatment. Similarly, we have no intention for our community to believe the stories told are the outcomes that would be achieved for every patient.
Home Privacy Policy Disclaimer Genea Group
© Copyright 2021 Genea Limited. ABN 82 002 844 448